Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy

Cancer Research

Volumn 64, Issue 24, 2004, Pages 8795-8799

  Stagg, John ^a   Wu, Jian Hui ^a   Bouganim, Nathaniel ^a   Galipeau, Jacques ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 2; TUMOR CELL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; COMPUTER MODEL; CONTROLLED STUDY; DRUG POTENTIATION; GENETIC ENGINEERING; LIGAND BINDING; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MELANOMA B16; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; TRANSGENE;

AMINO ACID SEQUENCE; ANIMALS; ARTIFICIAL GENE FUSION; CANCER VACCINES; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE THERAPY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOTHERAPY; INTERLEUKIN-2; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; TRANSGENES; VACCINES, DNA;

EID: 10844248144     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1776     Document Type: Article

References (20)

1. Dranoff G. GM-CSF-based cancer vaccines. Immunol Rev 2002;188:147-54.
2. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature (Lond) 2001;411:380-4.
3. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor sumulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993;90:3539-43.
4. Baiocchi RA, Ward JS, Carrodeguas L, et al. GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder. J Clin Investig 2001;108:887-94.
5. Schiller JH, Hank JA, Khorsand M, et al. Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study. Clin Cancer Res 1996;2:319-30.
6. Skog AL, Wersall P, Ragnhammar P, Frodin JE, Mellstedt H. Treatment with GM-CSF and IL-2 in patients with metastatic colorectal carcinoma induced high serum levels of neopterin and sIL-2R, an indicator of immune suppression. Cancer Immunol Immunother 2002;51:255-62.
7. Lee SG, Heo DS, Yoon SJ, et al. Effect of GM-CSF and IL-2 co-expression on the anti-tumor immune response. Anticancer Res 2000;20:2681-6.
8. Gillies SD, Lan Y, Brunkhorst B, Wong WK, Li Y, Lo KM, et al. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer. Cancer Immunol Immunother 2002;51:449-60.
9. Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. Cancer Res 1999;59:2384-94.
10. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation database search programs. Nucleic Acids Res 1997;25:3389-402.
11. Sali A, Blundell TL. Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol 1993;234:779-815.
12. Laskowski RA, Moss DS, Thornton JM. Main-chain bond lengths and bond angles in protein structures. J Mol Biol 1993;231:1049-67.
13. Steger GG, Kaboo R, deKernion JB, Figlin R, Belldegrun A. The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma. Br J Cancer 1995;72:101-7.
14. Grabstein KH, Urdal DL, Tushinski RJ, et al. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science (Wash DC) 1986;232:506-8.
15. Malkovsky M, Loveland B, North M, et al. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature (Lond) 1987;325:262-5.
16. Pericle F, Liu JH, Diaz JI, et al. Interleukin-2 prevention of apoptosis in human neutrophils. Eur J Immunol 1994;24:440-4.
17. Wei S, Liu JH, Epling-Burnette PK, et al. Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. J Immunol 1996;157:5155-62.
18. Cebon J, Dempsey P, Fox R, et al. Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay. Blood 1988;72:1340-7.
19. Faisal M, Cumberland W, Champlin R, Fahey JL. Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia. Blood 1990;76:1580-5.
20. Taguchi K, Shibuya A, Inazawa Y, Abe T. Suppressive effect of granulocyte-macrophage colony-stimulating factor on the generation of natural killer cells in vitro. Blood 1992;79:3227-32.